CRI to Host Second Annual Spanish-Language Virtual Immunotherapy patient Summit The free online event will connect cancer patients and caregivers with the latest promising research findings shared... September 6, 2022November 3, 2022
CRI Names Newest Class of STARs Six U.S. scientists have been awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer... June 22, 2022October 10, 2022
Cellular Cancer Immunotherapy Therapy Landscape Update Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends... June 1, 2022October 25, 2022
10th Annual Cancer Immunotherapy Month™ Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy... May 27, 2022October 14, 2022
First Patients in Ovarian Cancer Trial First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian... May 11, 2022July 13, 2022
PD1/PDL1 Immuno-Oncology Landscape Trends CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points... February 10, 2022October 12, 2022
